Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients
- 1 October 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (10) , 1859-1865
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation*Pediatric Transplantation, 2006
- Mechanisms of action of mycophenolate mofetilLupus, 2005
- Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft functionClinical Transplantation, 2004
- Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney TransplantationAmerican Journal of Transplantation, 2004
- Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapyTransplant International, 2004
- Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Concentrations in Stable Renal Transplant PatientsClinical Pharmacokinetics, 2004
- The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†Drug Metabolism Reviews, 2001
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986